ArticleScientific reports2025

Tapping the untapped: type II L-asparaginase from marine crustacean-derived Chryseomicrobium amylolyticum as a potential bio better for blood cancer therapy.

V P Lailaja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.